Medicx Launches Medicx Profiler

Medicx Profiler will give clients patient personas with in-depth analyses of their target audiences

Medicx Health announces the launch of Medicx Profiler. With Medicx Profiler, pharmaceutical marketers will gain greater insight and clarity as to who their target patients are, not just as patients, but also as consumers.

Marketing Technology News: Avatier Unveils 2021 Spring Release Identity Anywhere Suite

Medicx Profiler allows pharmaceutical marketers to truly connect with their current or prospective patient community. Marketers must know who they are trying to connect with and must understand them. Medicx Profiler allows them to create patient persona’s so they profile their audiences as patients, and as consumers.

With the insights gained from Medicx Profiler, which include patient health attribute data, demographics, lifestyles, attitudes and media preferences, clients will have an in-depth understanding of who their patients are. These insights can then guide future planning, creative development, channel allocation, target execution and much more.

Marketing Technology News: MarTech Interview with Ben Brenner, VP of Business Development and Strategy at Digital Remedy

Michael Weintraub, CEO of Medicx Health commented that “with Medicx Profiler, now there is a way to ensure a pharmaceutical marketer’s ideal patient receives a targeted message that will encourage, nurture and convert them. It’s a weapon to reach patients with individualized and relevant messages.”

Lauren Jacobson, Group Director Performance Acceleration at Initiative, stated “Medicx has brought value beyond audience development with great innovation in Closed Loop Measurement and holistic planning tools, such as Medicx Profiler. Now looking to 2022 planning I can’t imagine Medicx not having a seat at the table!”

Brought to you by
For Sales, write to: contact@martechseries.com
Copyright © 2024 MarTech Series. All Rights Reserved.Privacy Policy
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.